MAM
Swarovski elevates Francis Belin to sr VP consumer goods business APAC
MUMBAI: In a recent development, Swarovski has promoted Francis Belin to take a bigger role in the company.
Belin who has been in charge of Swarovski’s consumer goods business for Greater China since August 2011, has now been elevated to senior vice president consumer goods business APAC.
Based in Hong Kong, Belin is responsible for the strategic direction and the development of the company in China, Taiwan, Hong Kong and Macao.
Starting from April 2014, he has extended his scope – beyond Greater China – to take over Swarovski’s consumer good business for Asia Pacific, including key markets like Japan, Korea, Australia and India. Belin is also a member of the Board of Advisors of Kid’s Earth Fund (Japan) and since April 2013, has been appointed to the advisory committee of the Swarovski Foundation.
He joined Swarovski in January 2008 as Managing Director for Japan. Under Belin’s leadership, Japan has achieved to be the second fastest growing market in the world after Mainland China, thanks to major upgrades in brand positioning, brand awareness and distribution network. Prior to joining Swarovski, Belin started his career in Management consulting at McKinsey&Co in Europe and Asia, and worked as Managing Director of Jaeger-LeCoultre (Richemont) in Japan.
Originally from France, Belin holds a degree in Management from the ESSEC Business School in France and a Diploma Kaufmann from the University of Mannheim in Germany, majoring in Business administration and Psychology.
MAM
Beacon Group appoints Dr Rajesh Patel as Group CEO
36-year healthcare veteran to lead Beacon Diagnostics, Vector Biotek, Biogeny.
MUMBAI: A new chief, a fresh diagnosis and a sharper prescription for growth. Beacon Group has appointed Dr Rajesh Patel as its Group Chief Executive Officer, effective April 1, 2026, signalling a decisive push to scale its presence in the diagnostics and IVD space. Patel steps into the role with 36 years of experience across the healthcare and diagnostics industry, bringing a career shaped by leadership roles spanning sales, marketing, business development and operational strategy. His mandate is both expansive and precise: to steer the group’s overall strategic direction while tightening coordination across its three core entities Beacon Diagnostics, Vector Biotek and Biogeny Diagnostics.
In practical terms, that means driving cross-company synergies, accelerating market expansion and strengthening organisational capability areas increasingly critical as diagnostic players compete for scale in a fragmented yet rapidly evolving healthcare ecosystem. The group is positioning itself to capture unmet demand across chain laboratories, key accounts and standalone labs, segments that remain underserved despite growing diagnostic needs.
The appointment comes at a time when the In Vitro Diagnostics (IVD) sector in India is entering a more competitive and innovation-led phase, with companies focusing not just on product pipelines but also on service delivery, integration and customer-centric models. Beacon’s leadership appears to be betting that Patel’s execution-focused approach can help translate ambition into operational momentum.
Welcoming the appointment, Chairman Dr D K Joshi described Patel’s induction as a strategic move aligned with the group’s long-term vision, emphasising the role of leadership depth in navigating the next phase of growth.
For Beacon Group, the message is clear, in a sector where precision matters, leadership is the new differentiator—and this appointment is intended to set the tone for what comes next.
